| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $254.4M | -1.8% |
| R&D Expense | $86.1M | -18.7% |
| SG&A Expense | $121.2M | -4.3% |
| Operating Income | -$217.5M | +68.6% |
| Pre-tax Income | -$206.8M | +69.4% |
| Income Tax | $2.8M | -28.7% |
| Net Income | -$208.1M | +69.2% |
| EPS (Basic) | -$13.88 | -483.2% |
| EPS (Diluted) | -$13.88 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $228.3M | -38.6% |
| Accounts Receivable | $71.9M | +32.8% |
| Inventory | $2.9M | -57.0% |
| Current Assets | $317.0M | -29.5% |
| Total Assets | $436.0M | -26.1% |
| Current Liabilities | $111.3M | +18.6% |
| Total Liabilities | $119.7M | +9.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$127.3M | +14.2% |
| Capital Expenditures | $119K | -38.0% |
| Investing Cash Flow | -$18.7M | +2.7% |
| Financing Cash Flow | $1.4M | -35.7% |
| Free Cash Flow | -$127.5M | +14.2% |
| -483.2% |
| Stockholders' Equity |
| $304.8M |
| -34.3% |